Atıf Formatları
Inhibition of PKC activity with Byrostatin alters secretion of inflammatory chemokines.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

N. Erin And E. Tavşan, "Inhibition of PKC activity with Byrostatin alters secretion of inflammatory chemokines. ," 14th CIMT Annual Meeting, mechanisms of effıcacy in cancer immunotherapy , Mainz, Germany, 2016

Erin, N. And Tavşan, E. 2016. Inhibition of PKC activity with Byrostatin alters secretion of inflammatory chemokines. . 14th CIMT Annual Meeting, mechanisms of effıcacy in cancer immunotherapy , (Mainz, Germany).

Erin, N., & Tavşan, E., (2016). Inhibition of PKC activity with Byrostatin alters secretion of inflammatory chemokines. . 14th CIMT Annual Meeting, mechanisms of effıcacy in cancer immunotherapy, Mainz, Germany

Erin, NURAY, And ESRA TAVŞAN. "Inhibition of PKC activity with Byrostatin alters secretion of inflammatory chemokines. ," 14th CIMT Annual Meeting, mechanisms of effıcacy in cancer immunotherapy, Mainz, Germany, 2016

Erin, NURAY And Tavşan, ESRA. "Inhibition of PKC activity with Byrostatin alters secretion of inflammatory chemokines. ." 14th CIMT Annual Meeting, mechanisms of effıcacy in cancer immunotherapy , Mainz, Germany, 2016

Erin, N. And Tavşan, E. (2016) . "Inhibition of PKC activity with Byrostatin alters secretion of inflammatory chemokines. ." 14th CIMT Annual Meeting, mechanisms of effıcacy in cancer immunotherapy , Mainz, Germany.

@conferencepaper{conferencepaper, author={NURAY ERİN And author={ESRA TAVŞAN}, title={Inhibition of PKC activity with Byrostatin alters secretion of inflammatory chemokines. }, congress name={14th CIMT Annual Meeting, mechanisms of effıcacy in cancer immunotherapy}, city={Mainz}, country={Germany}, year={2016}}